| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ATRA | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0002 |
| mRNA | RO-3306 | GDSC1000 | pan-cancer | AAC | 0.12 | 0.0004 |
| mRNA | BRD-K04800985 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0005 |
| mRNA | Vorinostat | CTRPv2 | pan-cancer | AAC | 0.11 | 0.0006 |
| mRNA | Dasatinib | CTRPv2 | pan-cancer | AAC | -0.12 | 0.0008 |
| mRNA | BRD-K16147474 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0009 |
| mRNA | 17-AAG | GDSC1000 | pan-cancer | AAC | 0.1 | 0.001 |
| mRNA | ISOX:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.11 | 0.001 |
| mRNA | OSI-906 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.002 |
| mRNA | BRD-K29313308 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.002 |